Cloud DX Announces Contracts with US Primary Care Clinics

3 years ago

Cloud DX and partner Maxwell Telecare sign three new clinics for Remote Patient Monitoring (RPM) deployment, expanding on its Maxwell…

Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console

3 years ago

REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

WithHealth Publishes Whitepaper on Strengthening Workplace Safety

3 years ago

What employers must do, can do, and should do to protect their workforce and their customers from COVID-19SAN DIEGO, CA…

NeoGenomics Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program

3 years ago

FT. MYERS, FL / ACCESSWIRE / January 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…

Syneos Health Releases 2022 Dealmakers’ Intentions Survey

3 years ago

As Industry Dynamics Shift, Smaller Biotechnology Companies Will Continue to Drive Dealmaking in 2022MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) --…

Parexel Bolsters Regulatory and Access Offering with Key Appointment

3 years ago

Former Health Advances Partner Wyatt Gotbetter appointed Head of Parexel Worldwide Access Consulting to drive growth in consulting businessBOSTON, and…

Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company

3 years ago

-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple…

T2 Biosystems Announces the Initiation of the T2Resistance® Panel Clinical Trial

3 years ago

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…

Resonant Recognized as One of the Three Leading BAW Filter Innovators Since the Start of 2020

3 years ago

Company’s Intellectual Property Portfolio Expands to over 415 Filed or Issued Patents; 265 of Which are Focused on XBAR® (BAW)…

Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Kingdom

3 years ago

SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) announced that the United Kingdom’s Home…